Merck Will Acquire Biotech Firm Idenix
Monday, June 9, 2014 - 14:52
in Mathematics & Economics
Pharmaceuticals: Deal for close to $4 billion brings key addition to its hepatitis C virus portfolio
Updated by artificial intelligence Tue, 13 Jun 2023, 2:53:47 UTC Learn more
- Tell your friends
- Get science news via